CDK5R2 and neuroblastoma: Studies have shown that CDK5R2 CYP26B1, DCAF8L1, PAGE1, and TRIM36 can be used to construct prognostic models or prognostic biomarker for HCC, rectal cancer, neuroblastoma, etc [43–47].